StonvexLoading…
StonvexStonvexStonvexCore line items from ABT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.16B | $44.33B | $32.87B | $21.50B |
Operating Income | $1.34B | $8.05B | $5.80B | $3.75B |
Net Income | $1.08B | $6.52B | $4.75B | $3.10B |
EPS (Diluted) | $0.61 | $3.72 | $2.70 | $1.77 |
Total Assets | $110.43B | $86.71B | $84.18B | $84.00B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $6.80B | $8.52B | $7.51B | $6.95B |
Free Cash Flow OCF − CapEx | $916.00M | $7.39B | $4.77B | $2.48B |
Shares Outstanding | 1.75B | 1.75B | 1.75B | 1.75B |